Related Experiment Video
Updated: Aug 5, 2026
12:11
Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes
Published on: August 27, 2015
A simple screening test for fatty acid oxidation defects using whole-blood palmitate oxidation
L E Seargeant1, K Balachandra, C Mallory
1Department of Pediatrics, University of Manitoba, Winnipeg, Canada.
Journal of Inherited Metabolic Disease
|September 3, 1999
Summary
A new whole-blood assay offers a rapid and inexpensive screening method for fatty acid oxidation defects. This test measures palmitate oxidation, with low levels indicating potential beta-oxidation defects in patients.
Area of Science:
- Biochemistry
- Metabolic Disorders
- Clinical Diagnostics
Background:
- Fatty acid oxidation defects are serious metabolic disorders.
- Accurate and accessible screening tests are crucial for early diagnosis.
- Existing diagnostic methods can be complex or time-consuming.
Purpose of the Study:
- To develop and validate a rapid, inexpensive screening test for fatty acid oxidation defects.
- To adapt existing assays for use with whole-blood samples.
- To establish whole-blood palmitate oxidation as a reliable biomarker.
Main Methods:
- Adapted existing assays for whole-blood samples.
- Incubated micro whole-blood samples with tritiated palmitic acid.
- Measured tritiated water production as an indicator of beta-oxidation.
Main Results:
- Whole-blood palmitate oxidation assay is rapid and inexpensive.
- Assay is adapted from fibroblast and white blood cell methods.
- Low whole-blood palmitate oxidation correlates with confirmed beta-oxidation defects.
Conclusions:
- Whole-blood palmitate oxidation measurement is a viable screening test.
- The assay provides a practical approach for identifying patients with fatty acid oxidation defects.
- This method can facilitate earlier diagnosis and intervention for affected individuals.
